DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 53 filers reported holding DERMA SCIENCES INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $0 | – | 15 | 0.0% | 0.00% | – |
Q3 2016 | $0 | – | 15 | 0.0% | 0.00% | – |
Q2 2016 | $0 | -100.0% | 15 | -97.9% | 0.00% | – |
Q1 2016 | $2,000 | -75.0% | 725 | -60.3% | 0.00% | – |
Q4 2015 | $8,000 | -70.4% | 1,825 | -68.6% | 0.00% | – |
Q3 2015 | $27,000 | -35.7% | 5,810 | 0.0% | 0.00% | – |
Q2 2015 | $42,000 | -19.2% | 5,810 | -5.6% | 0.00% | – |
Q1 2015 | $52,000 | -36.6% | 6,153 | -30.0% | 0.00% | – |
Q4 2014 | $82,000 | +115.8% | 8,785 | +90.8% | 0.00% | – |
Q3 2014 | $38,000 | -11.6% | 4,604 | +23.3% | 0.00% | – |
Q2 2014 | $43,000 | -79.7% | 3,734 | -77.7% | 0.00% | – |
Q1 2014 | $212,000 | +125.5% | 16,749 | +91.4% | 0.00% | – |
Q4 2013 | $94,000 | +70.9% | 8,752 | +99.3% | 0.00% | – |
Q3 2013 | $55,000 | -35.3% | 4,391 | -30.5% | 0.00% | – |
Q2 2013 | $85,000 | – | 6,316 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 507,799 | $1,574,000 | 1.86% |
Krensavage Asset Management, LLC | 906,046 | $2,809,000 | 1.01% |
DAFNA Capital Management LLC | 353,718 | $1,097,000 | 0.95% |
Broadfin Capital, LLC | 2,562,104 | $7,943,000 | 0.77% |
ROANOKE ASSET MANAGEMENT CORP/ NY | 124,549 | $386,000 | 0.18% |
Senvest Management, LLC | 489,807 | $1,518,000 | 0.13% |
Baker Brothers Advisors | 3,752,390 | $11,632,000 | 0.12% |
Perceptive Advisors | 432,884 | $1,341,000 | 0.12% |
Granahan Investment Management | 1,028,460 | $3,188,000 | 0.12% |
Alambic Investment Management, L.P. | 49,035 | $152,000 | 0.05% |